APA

Hoedemaker N. P. G., Damman P., Ottervanger J. P., Dambrink J. H. E., Gosselink A. T. M., Kedhi E., Kolkman E., de Winter R. J. & van 't Hof A. W. J. (20200518). Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry. : European heart journal. Cardiovascular pharmacotherapy.

Chicago

Hoedemaker Niels P G, Damman Peter, Ottervanger Jan Paul, Dambrink Jan Henk E, Gosselink A T Marcel, Kedhi Elvin, Kolkman Evelien, de Winter Robbert J and van 't Hof Arnoud W J. 20200518. Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry. : European heart journal. Cardiovascular pharmacotherapy.

Harvard

Hoedemaker N. P. G., Damman P., Ottervanger J. P., Dambrink J. H. E., Gosselink A. T. M., Kedhi E., Kolkman E., de Winter R. J. and van 't Hof A. W. J. (20200518). Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry. : European heart journal. Cardiovascular pharmacotherapy.

MLA

Hoedemaker Niels P G, Damman Peter, Ottervanger Jan Paul, Dambrink Jan Henk E, Gosselink A T Marcel, Kedhi Elvin, Kolkman Evelien, de Winter Robbert J and van 't Hof Arnoud W J. Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry. : European heart journal. Cardiovascular pharmacotherapy. 20200518.